Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

Trial Profile

Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 25 Dec 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
    • 25 Dec 2009 Actual start date (1 Apr 2007) and actual patient number (754) added as reported by ClinicalTrials.gov.
    • 12 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top